NCT01798589View on ClinicalTrials.gov

Bioequivalence of Ethylenediamine Dihydrochloride Study

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Allergic Contact Dermatitis
Interventions
DRUG

Ethylenediamine dihydrochloride allergen patch

1 allergen panel containing 2 allergen and 2 control patches

Trial Locations (1)

40202

Dermatology Specialists PSC, Louisville

Sponsors

Lead Sponsor

Allerderm
All Listed Sponsors
lead

Allerderm

INDUSTRY

NCT01798589 - Bioequivalence of Ethylenediamine Dihydrochloride Study | Biotech Hunter | Biotech Hunter